Frankfurt - Delayed Quote EUR

Corvus Pharmaceuticals, Inc. (C17.F)

Compare
4.7600
+0.0150
+(0.32%)
At close: January 30 at 8:12:27 AM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
45,553.0000
68,240.0000
109,455.0000
85,529.0000
Total Liabilities Net Minority Interest
6,869.0000
12,125.0000
12,293.0000
13,381.0000
Total Equity Gross Minority Interest
38,684.0000
56,115.0000
97,162.0000
72,148.0000
Total Capitalization
38,684.0000
56,115.0000
97,162.0000
72,148.0000
Common Stock Equity
38,684.0000
56,115.0000
97,162.0000
72,148.0000
Capital Lease Obligations
1,374.0000
2,601.0000
3,647.0000
2,310.0000
Net Tangible Assets
38,684.0000
56,115.0000
97,162.0000
72,148.0000
Working Capital
21,087.0000
32,912.0000
61,620.0000
33,187.0000
Invested Capital
38,684.0000
56,115.0000
97,162.0000
72,148.0000
Tangible Book Value
38,684.0000
56,115.0000
97,162.0000
72,148.0000
Total Debt
1,374.0000
2,601.0000
3,647.0000
2,310.0000
Share Issued
49,038.5820
46,553.5110
46,553.5110
28,372.6340
Ordinary Shares Number
49,038.5820
46,553.5110
46,553.5110
28,372.6340
12/31/2020 - 3/30/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers